Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors
NCT ID: NCT00644098
Last Updated: 2015-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
138 participants
INTERVENTIONAL
2008-09-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We believe that those participants taking 3-6 capsules per day of the treatment capsules over a 14 week period will loose a significant amount of weight compared to the placebo group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Effects of Dietary Fibres on the Gut Microbiome in a Transgenerational Cohort
NCT05364437
Canola Oil, Fibre and DHA Enhanced Clinical Trial
NCT02091583
Effect of Viscous Soluble Fibers on Serum Cholesterol Levels
NCT02068248
Effect of Fibre Products on Appetite and Weight
NCT00750438
Safety and Tolerability of Soy Fiber
NCT04499482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
cellulose and soybean oil
cellulose and soybean oil
Intervention
soluble fibre complex and medium chain triglycerides
soluble fibre complex and medium chain triglycerides
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
soluble fibre complex and medium chain triglycerides
cellulose and soybean oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Canadian Center for Functional Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Durance, PhD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Canadian Center for Functional Medicine
Coquitlam, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.